Oral contraceptive use during the perimenopausal years

American Family Physician

Volumn 58, Issue 6, 1998, Pages 1373-1377

  Van Winter, Jo T ^a   Bernard, Matthew E ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTREL; ORAL CONTRACEPTIVE AGENT; PLACEBO;

ADULT; ARTICLE; BREAST CANCER; CLINICAL TRIAL; ENDOMETRIUM CANCER; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MENOPAUSE; MULTICENTER STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; OVARY CANCER; RISK BENEFIT ANALYSIS; STROKE; TRANSDERMAL DRUG ADMINISTRATION;

BREAST NEOPLASMS; CEREBROVASCULAR DISORDERS; CONTRACEPTIVES, ORAL, HORMONAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; OSTEOPOROSIS; OVARIAN NEOPLASMS; PREMENOPAUSE;

EID: 0031768507     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Beck WW Jr. Use of oral contraceptives in women in their 40s. Postgrad Obstet Gynecol 1995;15(12):1.
2. Martinez F, Manubens M, Carreras O, Tur R, Barri PN. Ovarian function during hormonal replacement therapy in perimenopausal women. Adv Contracept 1993;9:71-4.
3. Bolaji II, Grimes H, Mortimer G, Talion DF, Fottrell PF, O'Dwyer EM. Low-dose progesterone therapy in oestrogenised postmenopausal women: effects on plasma lipids, lipoproteins and liver function parameters. Eur J Obstet Gynecol Reprod Biol 1993;48:61-8.
4. Connell EB. Rational use of oral contraceptives in the perimenopausal woman. J Reprod Med 1993; 38:1036-40.
5. Riggs BL, Melton LJ 3d. The prevention and treatment of osteoporosis. N Engl J Med 1992;327:620-7 [published erratum appears in N Engl J Med 1993;328:65].
6. Gambacciani M, Spinetti A, Cappagli B, Taponeco F, Maffei S, Piaggesi L, et al. Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: effects on bone mineral density and metabolism. Maturitas 1994;19:125-31.
7. DeCherney A. Bone-sparing properties of oral contraceptives. Am J Obstet Gynecol 1996;174:15-20.
8. Schlesselman JJ. Cancer of the breast and reproductive tract in relation to use of oral contraceptives. Contraception 1989;40:1-38.
9. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Engl J Med 1987;316:650-5.
10. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. Combination oral contraceptive use and the risk of endometrial cancer. JAMA 1987;257:796-800.
11. Grimes DA, Chaney EJ, Connell EB, Emans SJ, Goldzieher JW, Hillard PJ, et al. Health benefits of oral contraceptives. The Contraception Report. 1997;8(2):4-14.
12. Petitti DB, Sidney S, Bernstein A, Wolf S, Quesenberry C, Ziel HK. Stroke in users of low-dose oral contraceptives. N Engl J Med 1996;335:8-15.
13. Tzourio C, Tehindrazanarivelo A, Iglesias S, Alperovitch A, Chedru F, d'Anglejan-Chatillon J, et al. Case-control study of migraine and risk of ischaemic stroke in young women. BMJ 1995;310:830-3.
14. Carolei A, Marini C, De Matteis G. History of migraine and risk of cerebral ischaemia in young adults. The Italian National Research Council Study Group on Stroke in the Young. Lancet 1996;347:1503-6.
15. Oregon Health Sciences University School of Medicine. Current clinical issues in oral contraception. Contemp Ob/Gyn 1996;41 (Suppl):12.
16. Porcile A, Gallardo E, Onetto P, Schachter D. Very low estrogen-desogestrel contraceptive in perimenopausal hormonal replacement. Maturitas 1994; 18:93-103.
17. Collaborative Group on Hormonal Factors and Breast Cancer. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet 1996;347:1713-27.
18. Wingo PA, Lee NC, Ory HW, Beral V, Peterson HB, Rhodes P. Age-specific differences in the relationship between oral contraceptive use and breast cancer. Obstet Gynecol 1991;78:161-70.
19. Santoro N, Brown JR, Adel T, Skurnick JH. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996; 81:1495-501.
20. Castracane VD, Gimpel T, Goldzieher JW. When is it safe to switch from oral contraceptives to hormonal replacement therapy? Contraception 1995;52:371-6.
21. Gebbie AE, et al. Ovulation in perimenopausal women (abstract). OB GYN Clinical Alert 1996;12(9):70.
22. Speroff L. Contraception for older women. OB/GYN Clinical Alert 1994;11(5):38-40.